Search Results - Lars Bergmann
- Showing 1 - 20 results of 22
- Go to Next Page
-
1
-
2
-
3
Efficacy, safety and patient’s quality of life of long-term treatment with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease in Romania: Results from GLORIA observa... by Jozsef Szasz, Mihaela Simu, Lacramioara Perju-Dumbrava, Angelo Antonini, Lars Bergmann, Diana Popescu, Ovidiu Alexandru Bajenaru
Published in Romanian Journal of Neurology (2020-03-01)Get full text
Article -
4
Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson’s disease individuals by Yi Rang Han, Anna Jeong, Kanwal Ayub, Shelly V. Gupta, Lars Bergmann, Drew S. Kern, Fernando Pagan, Matthew Rosebraugh
Published in Clinical Parkinsonism & Related Disorders (2025-01-01)Get full text
Article -
5
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa by Cindy Zadikoff, Werner Poewe, James T. Boyd, Lars Bergmann, Horia Ijacu, Pavnit Kukreja, Weining Z. Robieson, Janet Benesh, Angelo Antonini
Published in Parkinson's Disease (2020-01-01)Get full text
Article -
6
The <i>NFKB1</i> Promoter Polymorphism (-94ins/delATTG) Is Associated with Susceptibility to Cytomegalovirus Infection after Kidney Transplantation and Should Have Implications on... by Hartmuth Nowak, Svenja Vornweg, Katharina Rump, Tim Rahmel, Matthias Unterberg, Björn Koos, Peter Schenker, Richard Viebahn, Michael Adamzik, Lars Bergmann
Published in Cells (2021-02-01)Get full text
Article -
7
A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes. by Caroline Holtkamp, Björn Koos, Matthias Unterberg, Tim Rahmel, Lars Bergmann, Zainab Bazzi, Maha Bazzi, Hassan Bukhari, Michael Adamzik, Katharina Rump
Published in PLoS ONE (2019-01-01)Get full text
Article -
8
The Aquaporin 3 Promoter Polymorphism −1431 A/G is Associated with Acute Graft Rejection and Cytomegalovirus Infection in Kidney Recipients Due to Altered Immune Cell Migration by Katharina Rump, Tim Rahmel, Anna-Maria Rustige, Matthias Unterberg, Hartmuth Nowak, Björn Koos, Peter Schenker, Richard Viebahn, Michael Adamzik, Lars Bergmann
Published in Cells (2020-06-01)Get full text
Article -
9
Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study by Eric Freire-Alvarez, Paola Vanni, Egon Kurča, Lydia Lopez-Manzanares, Norbert Kovács, Cleanthe Spanaki, Tianming Gao, Lars Bergmann, Olga Sánchez-Soliño
Published in Neurology and Therapy (2024-02-01)Get full text
Article -
10
Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson’s disease by K. Ray Chaudhuri, Manon Bouchard, Eric Freire-Alvarez, Rajesh Pahwa, Lars Bergmann, Resmi Gupta, Pavnit Kukreja, Megha B. Shah, Stuart H. Isaacson
Published in Clinical Parkinsonism & Related Disorders (2025-01-01)Get full text
Article -
11
AQP5-1364A/C polymorphism and the AQP5 expression influence sepsis survival and immune cell migration: a prospective laboratory and patient study by Katharina Rump, Matthias Unterberg, Lars Bergmann, Agnes Bankfalvi, Anil Menon, Simon Schäfer, André Scherag, Zainab Bazzi, Winfried Siffert, Jürgen Peters, Michael Adamzik
Published in Journal of Translational Medicine (2016-11-01)Get full text
Article -
12
Satisfaction with videoconferencing support for levodopa-carbidopa intestinal gel: An observational study by Tanya Gurevich, Andrew Evans, Sharon Hassin-Baer, Georg Kägi, Dariusz Koziorowski, Anna Roszmann, Lars Bergmann, Juan Carlos Parra Riaza, Olga Sánchez-Soliño, Jarosław Sławek
Published in Digital Health (2024-08-01)Get full text
Article -
13
Employing artificial intelligence for optimising antibiotic dosages in sepsis on intensive care unit: a study protocol for a prospective observational study (KI.SEP) by Tim Rahmel, Michael Adamzik, Hartmuth Nowak, Lars Bergmann, Björn Koos, Martin Eisenacher, Barbara Sitek, Britta Marko, Lars Palmowski, Andrea Witowski, Katharina Rump, Julia Bandow, Patrick Günther
Published in BMJ Open (2024-12-01)Get full text
Article -
14
Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive... by Angelo Antonini, K. Ray Chaudhuri, Josefa Domingos, Joohi Jimenez-Shahed, Jack Wright, Connie H. Yan, Ali Alobaidi, Lars Bergmann, Koray Onuk, Linda Harmer, Irene A. Malaty
Published in BMC Neurology (2024-07-01)Get full text
Article -
15
Impact of glucocorticoid receptor polymorphism rs6198 on sepsis survival in a prospective multicenter cohort by Christoph Sombetzki, Lars Palmowski, Dominik Ziehe, Hartmuth Nowak, Tim Rahmel, Stefan Felix Ehrentraut, Patrick Thon, Jennifer Orlowski, Lars Bergmann, Michael Adamzik, Björn Koos, Katharina Rump, SepsisDataNet.NRW research group
Published in Scientific Reports (2025-07-01)Get full text
Article -
16
Persistent mortality in critical COVID-19 ICU cases from wild-type to delta variant: A descriptive cohort study by Lars Palmowski, André Hagedorn, Andrea Witowski, Helge Haberl, Felix Kraft, Ute Achtzehn, Detlef Kindgen-Milles, Kai Zacharowski, Axel Nierhaus, Maximilian Dietrich, Valbona Mirakaj, Thea Koch, Patrick Meybohm, Michael Adamzik, Lars Bergmann, Tim Rahmel
Published in Scientific Reports (2025-03-01)Get full text
Article -
17
The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis by Patrick Thon, Katharina Rump, Annika Knorr, Birte Dyck, Dominik Ziehe, Matthias Unterberg, Hartmuth Nowak, Lars Bergmann, Alexander Wolf, Maha Bazzi, Jennifer Orlowski, Marcus Peters, Alexander Zarbock, Thorsten Brenner, Michael Adamzik, Tim Rahmel, Björn Koos
Published in Cells (2022-09-01)Get full text
Article -
18
Mortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohortResearch in context by Lars Palmowski, Maike Weber, Malte Bayer, Yuxin Mi, Karin Schork, Martin Eisenacher, Hartmuth Nowak, Tim Rahmel, Lars Bergmann, Andrea Witowski, Björn Koos, Katharina Rump, Dominik Ziehe, Ulrich Limper, Dietrich Henzler, Stefan Felix Ehrentraut, Alexander Zarbock, Roman Fischer, Julian C. Knight, Michael Adamzik, Barbara Sitek, Thilo Bracht
Published in EBioMedicine (2025-01-01)Get full text
Article -
19
The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19 by Britta Westhus, Patrick Thon, Lars Palmowski, Katharina Rump, Björn Koos, Frederik Wiebel, Birte Dyck, Martin Eisenacher, Martin Eisenacher, Barbara Sitek, Barbara Sitek, Stephanie Pfaender, Stephanie Pfaender, Nina Babel, Moritz Anft, Christian Putensen, Stefan Felix Ehrentraut, Christina Weisheit, Alexander Zarbock, Thilo von Groote, Andrea Witowski, Matthias Unterberg, Hartmuth Nowak, Hartmuth Nowak, Alexander Wolf, Lars Bergmann, Michael Adamzik, Dominik Ziehe, Tim Rahmel
Published in Frontiers in Immunology (2025-05-01)Get full text
Article -
20
Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis by Dominik Ziehe, Alexander Wolf, Tim Rahmel, Hartmuth Nowak, Helge Haberl, Lars Bergmann, Katharina Rump, Birte Dyck, Lars Palmowski, Britta Marko, Andrea Witowski, Katrin Maria Willemsen, Stephanie Pfaender, Martin Eisenacher, Martin Eisenacher, Moritz Anft, Nina Babel, Thilo Bracht, Thilo Bracht, Barbara Sitek, Barbara Sitek, Malte Bayer, Malte Bayer, Alexander Zarbock, Thilo von Groote, Christian Putensen, Stefan Felix Ehrentraut, Christina Weisheit, Michael Adamzik, Matthias Unterberg, Björn Koos
Published in Frontiers in Immunology (2024-05-01)Get full text
Article
